← Leaderboards
Karen McFarlane Holman
Stanford University
$1,993
Attributed
$1,993
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6K · FY2010–11$2K$1.5K$1K$500$0
'10
'11
Funding mix
By agency
NIH$1,993 · 3
By mechanism
P41$1,993 · 3
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Daria Mochly-Rosen$28,932,521
- Calvin J Kuo$48,363,495
- Alain T Laederach$10,599,550
- Yunzhi Yang$11,928,757
- Chaitan Khosla$26,183,068
Others in their field
Top investigators on “Adduct”
- Stephen S Hecht · University Of Minnesota$41,864,752
- John M Essigmann · Massachusetts Institute Of Technology$25,721,710
- Robert J. Turesky · University Of Minnesota$19,878,824
- F Peter Guengerich · Vanderbilt University$19,243,238
- Frederica P Perera · Columbia University Health Sciences$18,043,364
- Bhagavatula Moorthy · Baylor College Of Medicine$17,486,719
Research focus
AdductAntineoplastic AgentsFundingGrantResourcesRutheniumSourceTransferrinUnited States National Institutes Of HealthRadiationAmino AcidsResearch InfrastructureDrug Binding SiteStructural BiologyBiomimeticsNational Center For Research ResourcesComplexCostPrincipal InvestigatorInsightComputer Retrieval Of Information On Scientific Projects DatabaseDrug DesignResearch PersonnelInstitution
Grant awards (3)
K-EDGE EXAFS ANALYSIS OF A RUTHENIUM ANTICANCER DRUG-TRANSFERRIN ADDUCT$1,368
P41 · FY2011 · RR · contact PI
RU K-EDGE EXAFS ANALYSIS OF A RUTHENIUM ANTICANCER DRUG-TRANSFERRIN ADDUCT$279
P41 · FY2011 · RR · contact PI
RU K-EDGE EXAFS ANALYSIS OF A RUTHENIUM ANTICANCER DRUG-TRANSFERRIN ADDUCT$346
P41 · FY2010 · RR · contact PI